Aerovate Therapeutics
Maha is a General Partner of Sofinnova Investments. She is an experienced investor in biopharma companies, with over two decades in venture capital investing and public equities portfolio management. She focuses on development stage investments in therapeutics.
This person is not in the org chart
This person is not in any offices
Aerovate Therapeutics
Aerovate is a clinical stage biopharmaceutical company focused on developing drugs that meaningfully improve the lives of patients with rare cardiopulmonary disease.